Cambridge Healthcare Research
Stephen is a trained neuropharmacologist and after quitting the academic world, joined Merck, first as a market researcher, and then as a product manager. Before he left, he was handling three Merck brands, all of which were market leaders.
Stephen joined Eli Lilly as International Product Manager to oversee imminent UK, EU & ME launches of Prozac, one of the most successful international drug launches in history.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Cambridge Healthcare Research
2 followers
The team at Cambridge Healthcare Research (CHR) provides strategic decision support and action planning to a wide range of stakeholders in the life-science and healthcare space. Working closely with our clients, CHR translates evolving treatment algorithms, patient pathways and novel technologies into tailored landscape analyses, commercial opportunity assessments, market models and into product sales forecasts. Our evaluation of market dynamics, combined with a targeted understanding of key trends in the prescriber, regulator, and payer environments, equips our clients to make the best decisions from an optimally informed position.